Kappa Bioscience (Oslo, Norway) has secured novel food approval for its non-soy vitamin K ingredient, K2Vital.
Kappa Bioscience (Oslo, Norway) has secured novel food approval for K2Vital, the company’s non-dairy, non-soy version of vitamin K2 menaquinone-7.
Vitamin K2, a type of vitamin K, has received increasing attention for cardiovascular and bone health support, with a heavy presence in global markers as a dietary supplement. The ingredient is understood for its role in activating osteocalcin, a protein required to move calcium from the blood to the bones.
In 2009, EFSA (Parma, Italy) supported an EU health claim for vitamin K and the maintenance of normal bone and normal blood coagulation.
Kappa Bioscience’s application for vitamin K2 novel food status was submitted to the German Food Safety Agency and ultimately acknowledged by all EU member states. The company’s ingredient is a synthetically vitamin K2 composed of trans-menaquinone-7. The ingredient is backed up by various toxicology studies and research indicating equivalent bioavailability and function when compared to natural vitamin K2 derived from bacterial fermentation.
K2Vital is also marketed as ActivK S by DuPont Danisco (Copenhagen).
PLT Health Solution's Bosewellia serrata extract granted updated license by Health Canada
August 27th 2024The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.